In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Clinical case submission rules and guidelines

EuroEcho-Imaging


 

Cases can be submitted via the online Clinical Case Submission Services only. Cases sent by fax or email will NOT be considered.

The submission deadline is Thursday 18 May 2017, midnight (CET/Paris Time). No late submissions will be accepted and there will be no deadline extension

All submitters have to submit an abstract and a PDF file

1 - Abstract

Intended for review and (if the case is selected) this will be the document published

Recommended structure of your case in the Abstract Content:

  1. Introduction and case report description 
  2. Description of the problem, procedures, techniques and/or equipment used (with images, if necessary – use pdf for further attachment)
  3. Questions, problems or possible differential diagnosis
  4. Answers and discussion
  5. Conclusions and implications for clinical practice

It is important that the Abstract constitutes a full presentation of the case within the recommended above structure.

Submissions which do not present a full abstract will not be validated.

2 - PDF (mandatory)

You must use the pdf to include additional images and to develop the case presentation.

The pdf will only be taken into consideration if the abstract is validated in its submission format and only as a complement to the abstract but it won’t be published.

See Step 4 below: Submission of the PDF file (mandatory) for more instructions.

Submission Period

The submission deadline is Thursday 18 May 2017, midnight (CET/Paris Time). No late submissions will be accepted and there will be no deadline extension

Draft Status

If you do not click on the submit button (Step 5 of the case submission service), your case will be saved in Draft Status. You will then be able to review it and submit it at a later time (but only before the deadline). NB: Cases that are in draft status after the deadline will not be considered for selection.

Changes and corrections

Once submitted, it is not possible to make any corrections to the content or information (such as Presenter details, topic, authors’ list etc.). In order to correct your case you must withdraw it and submit a new corrected version prior to the deadline (See below for withdrawal procedure). Note that, such replacement of a clinical case is not possible after the deadline. If errors in your case are discovered after the deadline, you may indicate the correction during the presentation at the congress. However, changes will not be included in the publications.

Withdrawal

If you want to withdraw a case already submitted, please notify us as quickly as possible at eescientific@escardio.org stating the title and number of the case to be withdrawn.

Note that, withdrawals are still accepted after the submission deadline but clinical cases may still appear in publications. All clinical case withdrawal requests must be received in writing (via e-mail) by the end of September 2017 to avoid publications.

Step 1: Clinical Case Information

Title

Maximum 200 characters typed in lower-case letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field.

Topic

Select one topic from the list of topics which best describes the content (for Case Evaluation). Make sure you select the appropriate topic as this choice will determine which graders will review your case.

Step 2: Clinical Case Authors

Your case must list at least 1 author in order to be submitted.

Authors list

Please note that the first author must be the Clinical Case Presenter by default.

You may enter up to 10 authors in the authors' list including the Presenter. Please make sure the information given for each author is correct, as no changes will be possible after the case is submitted (see paragraph on changes and corrections above).

The submitter certifies that he/she has permission from all persons he/she enters as co-authors to be listed in this case and that they are aware that their names will appear in all publications.

Institutions

This is a mandatory step.

You will be requested to select your institution when you create the presenter and the authors. Once you have entered your city, a list will automatically appear from which you can select your institution. You can add your department in the text box.

If your institution is not on the list, you have the possibility of creating it.

If your city is not on the list, please enter it, press enter then add your institution.

Step 3: Submission of the Abstract

All cases must be submitted in English using UK spelling with accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your case by a native English speaker, by a university scientific publications office (or another similar facility) prior to submission.

Images

We remind you that patient's photos should be avoided and the patient must never be identifiable in your presentation.

Important

As the grading and selection process is blinded, the title and body text MUST NOT contain information such as:

  • Names (authors or other)
  • Names of institute
  • Institute city name
Also not authorised

Trademarks. Use generic drug names. The use of commercial drug names is strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation

  • Company Names and location
  • Website and email addresses

This information may be deleted by the clinical case submission services and some rephrasing may occur.

Cases submitted on animal studies: Study must follow the "Principles of laboratory animal care" (NIH Publication no. 85-23 revised 1985) and according to the national law if applicable.

Please note that any medical research involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association. We remind you that patient’s photo should be avoided and the patient must never be identifiable in your presentation.

Recommended structure of your case in the Abstract Content:

  1. Introduction and case report description
  2. Description of the problem, procedures, techniques and/or equipment used (with images, if necessary – use pdf for further attachment)
  3. Questions, problems or possible differential diagnosis
  4. Answers and discussion
  5. Conclusions and implications for clinical practice

Do not cut and paste symbols into your text. Use the symbols provided when you click on the Ω button.

There is not a specific maximum of words, but rather a maximum total size of the case (shown as 100 %), including the text, table and picture (if any). The maximum size is 35 lines (3 000 characters).

  1. An image represents 11 lines (including the title)
  2. Each table row represents 1 line (+ 3 lines for title and legend)
  3. The table legend size is calculated by dividing its numbers of characters by 75.
  4. Use the save and refresh button at the bottom in order to display the size of the abstract in percentage (shown on the left side of the screen). The programme then converts the size in % to display to you when you register it as a draft.

The character limit does not include the title and the authors. Only the abstract text, table and picture are taken into account.

Abstract table

The Table field holds a table without surrounding text. Do NOT COPY your table into the field. You must RECREATE your table using the tools provided.

The maximum size of the table is 12 columns and 20 rows, and you can only enter one table. The title field is optional.

Abstract picture

Your picture file must meet the following criteria:

  • Format: JPEG or GIF
  • Size: less than 1 MB
  • Measures no larger than 800 pixels(x) x 600 pixels(y)

Please make sure that your picture is readable on the abstract preview (this represents how it will look in all publications). You can only enter one picture, and the title field is optional.

Step 4 of 5: Submission of the PDF file

The PDF file is mandatory and must be inserted to include additional pictures/images to develop and illustrate the case presentation.

Do not repeat the title of the case and do not copy exactly the abstract content of the PDF file, you must develop the case in the PDF to give additional information that will help to understand the case.

It is essential to include some words about what is the learning point of the case.

Important

As the grading and selection process is blinded, the PDF MUST NOT contain information such as:

  • Names (authors or other)
  • Names of institute
  • Institute city name
  • Website and email addresses

If any of this information is included in the PDF, the submission will be rejected as we cannot edit nor modify the pdf version.

Attachments

PDF with a maximum of 3 pages and a maximum of 50 Mb can be submitted.

Images

We remind you that patient's photos should be avoided and the patient must never be identifiable in your presentation.

Step 5: Clinical Case Preview and Submission

Please read through your case carefully before submitting it, as you cannot change it once submitted.

Do not forget to click on the “Submit” button to validate your case submission. You will receive an automatic confirmation by email (please make sure to state your correct email address) notifying you the case number. Please use this reference in all correspondence. If you do not receive this confirmation for one or more of your case(s), please contact the Scientific Programme Department at eescientific@escardio.org

There is no limit to the number of cases an author/individual may submit, but you should not submit the same twice, even under a different topic or with a different title. If you submit two cases with the same content, the online submission service will automatically keep the most recent case submitted and withdraw the other. Note that duplicate draft cases will not be deleted.

Clinical Case results

An email message will be sent to each Clinical Case Submitter by mid-July 2017 with a report on the status of the case (accepted or rejected).

If the case is accepted, a 2nd email will be sent to the 1st author, who is the presenter by default, with instructions to confirm the presentation and submit the agreement form.

Submission of a clinical case constitutes a commitment by the 1st author to present if accepted. Failure to present and register for the Congress, if not justified, may jeopardise future acceptance of cases.

Publication of cases and Embargo

Accepted cases are under embargo until one week before the congress. At that time they will be available on the Scientific Programme & Planner through the ESC Website, and also on the EuroEcho-Imaging 2017 Mobile App.

All accepted cases will be published in the abstract supplement of the European Heart Journal - Cardiovascular Imaging.

Until presentation at EuroEcho-Imaging Congress 2017, accepted cases should not be published in any other journals and/or online publications or presented at any international congresses.

Breaking of the Embargo Policy by a presenter or co-author will lead to:

  1. Withdrawal of their presentation from the EuroEcho-Imaging Scientific Session
  2. Retraction from all ESC publications
  3. Prohibition of submitting abstracts/cases to any ESC congresses for one year

Affirmation of Originality and Copyright transfer statement

  1.  By submitting your work to the ESC, you consent to have authors’ names, affiliation and biographical material being used in connection with the publication of your work.
  2. Author(s) represents and warrants that he/she/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.
  3. The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders and that all statements declared as facts are based on thorough examination and investigation for accurateness.
  4. Submitted clinical cases should not have been published in any other journals and/or online publications nor presented at any previous international congress. However, former presentation at national meetings does not disqualify. An author submitting or presenting published work may jeopardise future acceptance of abstracts and clinical cases.
  5. The content belongs to the author(s). However if the clinical case is accepted the submitter agrees, on behalf of all co-authors, to transfer and assign to the ESC the rights to edit, publish, reproduce, distribute copies and prepare derivative works such as press release or educational products. This includes use in indexes or search databases in print, electronic, or other media.
  6. Author(s) retain the right, after a presentation at the Congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits provided said use does not imply the endorsement of the ESC.

The submitter signs for all co-authors. He/she accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.

Conflict of interest

The Congress Programme Committee requests all presenters to disclose a potential conflict of interest. Clinical Case Presenters are requested to disclose potential conflicts of interest regarding their presentation in the first slide if presented in an oral session or at the bottom of their poster - if presented in the poster area. This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.

Data Privacy

By certifying that you have read these Submission rules, you also confirm having received the prior approval from the co-authors to provide their data to the ESC. You have personal data, which is, according to the Law on data processing and Civil Liberties 78-17 of 6 January 1978 modified, registered with the European Society of Cardiology (ESC).

The information you supply on this application is required to process it and it will be held in the ESC customer data files. It may be used for marketing and communication purposes by the ESC and its contractors only. You have the absolute right to access, amend and oppose any use of this personal data by writing to the ESC at the address mentioned below:

European Society of Cardiology
The European Heart House
Les Templiers
2035 Route des Colles
CS 80179 Biot
06903 Sophia-Antipolis Cedex – France